CN100389776C - Cm101在制备药物中的用途 - Google Patents
Cm101在制备药物中的用途 Download PDFInfo
- Publication number
- CN100389776C CN100389776C CNB988029065A CN98802906A CN100389776C CN 100389776 C CN100389776 C CN 100389776C CN B988029065 A CNB988029065 A CN B988029065A CN 98802906 A CN98802906 A CN 98802906A CN 100389776 C CN100389776 C CN 100389776C
- Authority
- CN
- China
- Prior art keywords
- wound
- patient
- purposes
- tumor
- mice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Environmental Sciences (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (16)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/791,763 | 1997-01-29 | ||
US08/791,763 US5858991A (en) | 1997-01-29 | 1997-01-29 | Facilitation of wound healing with CM101/GBS toxin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1251998A CN1251998A (zh) | 2000-05-03 |
CN100389776C true CN100389776C (zh) | 2008-05-28 |
Family
ID=25154717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB988029065A Expired - Fee Related CN100389776C (zh) | 1997-01-29 | 1998-01-29 | Cm101在制备药物中的用途 |
Country Status (13)
Country | Link |
---|---|
US (3) | US5858991A (zh) |
EP (1) | EP0973531B1 (zh) |
JP (1) | JP2001509169A (zh) |
CN (1) | CN100389776C (zh) |
AT (1) | ATE236647T1 (zh) |
AU (1) | AU6051898A (zh) |
DE (1) | DE69813200T2 (zh) |
DK (1) | DK0973531T3 (zh) |
ES (1) | ES2196539T3 (zh) |
HK (1) | HK1027755A1 (zh) |
IL (1) | IL131001A0 (zh) |
PT (1) | PT973531E (zh) |
WO (1) | WO1998032453A1 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7129061B1 (en) * | 1996-08-07 | 2006-10-31 | Biogen Idec Ma Inc. | Tumor necrosis factor related ligand |
US5981508A (en) * | 1997-01-29 | 1999-11-09 | Vanderbilt University | Facilitation of repair of neural injury with CM101/GBS toxin |
US8609614B2 (en) * | 1998-07-22 | 2013-12-17 | Vanderbilt University | GBS toxin receptor compositions and methods of use |
US6803448B1 (en) * | 1998-07-22 | 2004-10-12 | Vanderbilt University | GBS toxin receptor |
BR0007556A (pt) | 1999-01-15 | 2001-10-23 | Biogen Inc | Antagonistas de tweak e de receptor de tweak e uso dos mesmos para tratar distúrbios imunológicos |
IL145710A0 (en) * | 2000-02-02 | 2002-07-25 | Univ Vanderbilt | Methods for preventing or attenuating pathoangiogenic conditions |
EP1363657A2 (en) * | 2000-05-08 | 2003-11-26 | Biogen, Inc. | Method for promoting neovascularization using a tweak agonist and an angiogenic factor |
US7208151B2 (en) * | 2001-09-12 | 2007-04-24 | Biogen Idec Ma Inc. | Tweak receptor agonists as anti-angiogenic agents |
WO2003086311A2 (en) | 2002-04-09 | 2003-10-23 | Biogen, Inc. | Methods for treating tweak-related conditions |
US8017145B2 (en) * | 2003-12-22 | 2011-09-13 | Conopco, Inc. | Exfoliating personal care wipe article containing an array of projections |
DK2529619T3 (en) | 2005-02-17 | 2016-01-11 | Biogen Ma Inc | Treatment of neurological disorders |
EP1885388B1 (en) | 2005-05-10 | 2013-09-11 | Biogen Idec MA Inc. | Treating and evaluating inflammatory disorders |
WO2006138219A2 (en) | 2005-06-13 | 2006-12-28 | Biogen Idec Ma Inc. | Methods of diagnosis / prognosis of inflammatory conditions |
US8877185B2 (en) | 2012-05-10 | 2014-11-04 | Stan S. Sastry | Managing and treating keloids |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5010062A (en) * | 1989-09-25 | 1991-04-23 | Vanderbilt University | Therapeutic agent and method of inhibiting vascularization of tumors |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS557014A (en) * | 1978-06-29 | 1980-01-18 | Chugai Pharmaceut Co Ltd | Antitumor agent and its preparation |
US5145676A (en) * | 1981-09-08 | 1992-09-08 | The Rockefeller University | Method and agents for promoting wound healing |
GB8330969D0 (en) * | 1983-11-21 | 1983-12-29 | Wellcome Found | Promoting healing |
US4882317A (en) * | 1984-05-10 | 1989-11-21 | Merck & Co., Inc. | Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency |
US4912093A (en) * | 1986-10-01 | 1990-03-27 | Marion Laboratories, Inc. | Use of synthetic sulfated saccharides to enhance wound healing |
US5302386A (en) * | 1986-04-16 | 1994-04-12 | Brigham And Women's Hospital, Inc. | Bacterial antigens, antibodies, vaccines and methods of manufacture |
US4895838A (en) * | 1988-03-09 | 1990-01-23 | Trustees Of Boston University | Method for provoking angiogenesis by administration of angiogenically active oligosaccharides |
US5225331A (en) * | 1991-04-25 | 1993-07-06 | National Research Council Of Canada | Immunoassay for detecting group b streptococcus |
US5160483A (en) * | 1991-05-07 | 1992-11-03 | The University Of Tennessee Research Corporation | Fragment of TNF-α for promoting wound healing |
US5382514A (en) * | 1992-03-31 | 1995-01-17 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | In vivo angiogenesis assay |
DE69232539T3 (de) * | 1992-10-28 | 2007-01-04 | Genentech, Inc., South San Francisco | Verwendung von anti-VEGF Antikörpern zur Behandlung von Krebs |
US5629327A (en) * | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
JPH11500119A (ja) * | 1995-02-16 | 1999-01-06 | エフ・ホフマン−ラ ロシュ アーゲー | インターロイキン12を用いる脈管形成の阻害 |
WO1997041844A1 (en) * | 1996-05-09 | 1997-11-13 | Alcon Laboratories, Inc. | Combinations of angiostatic compounds |
US5811403A (en) * | 1996-09-30 | 1998-09-22 | Vanderbilt University | Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity |
-
1997
- 1997-01-29 US US08/791,763 patent/US5858991A/en not_active Expired - Lifetime
-
1998
- 1998-01-29 IL IL13100198A patent/IL131001A0/xx unknown
- 1998-01-29 EP EP98903864A patent/EP0973531B1/en not_active Expired - Lifetime
- 1998-01-29 ES ES98903864T patent/ES2196539T3/es not_active Expired - Lifetime
- 1998-01-29 PT PT98903864T patent/PT973531E/pt unknown
- 1998-01-29 DK DK98903864T patent/DK0973531T3/da active
- 1998-01-29 DE DE69813200T patent/DE69813200T2/de not_active Expired - Fee Related
- 1998-01-29 WO PCT/US1998/001853 patent/WO1998032453A1/en active IP Right Grant
- 1998-01-29 AT AT98903864T patent/ATE236647T1/de not_active IP Right Cessation
- 1998-01-29 CN CNB988029065A patent/CN100389776C/zh not_active Expired - Fee Related
- 1998-01-29 JP JP53227698A patent/JP2001509169A/ja not_active Ceased
- 1998-01-29 AU AU60518/98A patent/AU6051898A/en not_active Abandoned
- 1998-10-07 US US09/167,774 patent/US6569838B1/en not_active Expired - Fee Related
-
2000
- 2000-11-03 HK HK00107007.6A patent/HK1027755A1/xx not_active IP Right Cessation
-
2003
- 2003-03-24 US US10/396,770 patent/US20030180331A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5010062A (en) * | 1989-09-25 | 1991-04-23 | Vanderbilt University | Therapeutic agent and method of inhibiting vascularization of tumors |
Non-Patent Citations (2)
Title |
---|
血管生成抑制剂与恶性肿瘤. 李龙江.口腔颌面外科,第6卷第1期. 1996 |
血管生成抑制剂与恶性肿瘤. 李龙江.口腔颌面外科,第6卷第1期. 1996 * |
Also Published As
Publication number | Publication date |
---|---|
EP0973531A1 (en) | 2000-01-26 |
CN1251998A (zh) | 2000-05-03 |
US20030180331A1 (en) | 2003-09-25 |
EP0973531B1 (en) | 2003-04-09 |
DK0973531T3 (da) | 2003-07-28 |
US6569838B1 (en) | 2003-05-27 |
JP2001509169A (ja) | 2001-07-10 |
ES2196539T3 (es) | 2003-12-16 |
AU6051898A (en) | 1998-08-18 |
WO1998032453A1 (en) | 1998-07-30 |
ATE236647T1 (de) | 2003-04-15 |
DE69813200T2 (de) | 2004-02-12 |
DE69813200D1 (de) | 2003-05-15 |
US5858991A (en) | 1999-01-12 |
HK1027755A1 (en) | 2001-01-23 |
PT973531E (pt) | 2003-08-29 |
IL131001A0 (en) | 2001-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100389776C (zh) | Cm101在制备药物中的用途 | |
MUELLER et al. | Intraperitoneal use of sodium carboxymethylcellulose in horses undergoing exploratory celiotomy | |
EP1001781A2 (en) | Use of taurolidine or taurultam for the manufacture of a medicament for the prevention of metastases | |
JPH05503286A (ja) | 骨における薬物送達のための生体侵食性ポリマー | |
US7151099B2 (en) | Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases | |
Winfrey et al. | Low molecular weight dextran in small artery surgery: Antithrombogenic effect | |
Cohn Jr et al. | Control of tumor implantation during operations on the colon | |
AU2017221883B2 (en) | Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process | |
JPH04502753A (ja) | フィブリンの沈着または癒着の予防のための方法および治療学的組成物 | |
Zhang et al. | A comparison of robot-assisted laparoscopic ureteral reimplantation and conventional laparoscopic ureteral reimplantation for the management of benign distal ureteral stricture | |
KEY et al. | The local use of sulfanilamide in various tissues | |
US6670337B1 (en) | Facilitation of wound healing with CM101/GBS toxin | |
RU2714949C2 (ru) | Способ моделирования местного отграниченного перитонита у крыс | |
Mori et al. | An experimental perfusion system using the rabbit Vx-2 carcinoma: I. Studies on the effect of drug perfusions and irradiation | |
Freedman et al. | Experimental pyelonephritis. VII. Evidence on the mechanisms by which obstruction of urine flow enhances susceptibility to pyelonephritis | |
Sosolik et al. | Clostridium sordellii toxic shock syndrome: a case report and review of the literature | |
RU2397771C2 (ru) | Способ лечения осложненных форм воспалительных заболеваний придатков матки | |
RU2337704C1 (ru) | Способ реабилитации рыб после хирургического вмешательства | |
McCROSKEY et al. | TRYPTIC DÉBRIDEMENT OF CLOTTED HEMOTHORAX: Experimental and Clinical Study | |
RU2143238C1 (ru) | Способ лечения прогрессирующей трубной беременности | |
RU2262942C2 (ru) | Способ обтурации наружных трубчатых свищей пищеварительного тракта и остаточных полостей абдоминальной области | |
SU1156660A1 (ru) | Способ лечени заболеваний органов пузырно-уретрального сегмента у мужчин | |
RU2141266C1 (ru) | Способ лечения неспецифического метроэндометрита | |
Recker et al. | Cyclosporine A impairs wound healing of ureterocystoneostomy in rats: Scanning electron microscopic examination | |
Jun et al. | Unexpected Intraocular Inflammation Following the Use of Anti-Adhesion Agents, Mediclore®-A Case Report |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: C. G. HELLERGVIST Free format text: FORMER OWNER: C. G. HELLERGVIST; YEDA RES + DEV Effective date: 20011114 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20011114 Address after: Tennessee, USA Applicant after: C.G.Hellerqvist Address before: American Tennessee Applicant before: C.G.Hellerqvist Applicant before: Yeda Research and Development Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1027755 Country of ref document: HK |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20000503 Assignee: Shanghai xinshengyuan Pharmaceutical Group Co. Ltd. Assignor: C.G.Hellerqvist Contract record no.: 2012990000633 Denomination of invention: The use of CM101 in the preparation of medicines Granted publication date: 20080528 License type: Exclusive License Record date: 20120829 |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080528 Termination date: 20150129 |
|
EXPY | Termination of patent right or utility model |